(Q48735189)

15 February 2018

title

Dopa decarboxylase genotypes may influence age at onset of schizophrenia. (English)

1 reference

15 February 2018

0 references

7

1 reference

15 February 2018

author name string

Børglum AD

1

1 reference

15 February 2018

Hampson M

2

1 reference

15 February 2018

Kjeldsen TE

3

1 reference

15 February 2018

Muir W

4

1 reference

15 February 2018

Murray V

5

1 reference

15 February 2018

Ewald H

6

1 reference

15 February 2018

Blackwood D

8

1 reference

15 February 2018

Kruse TA

9

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 November 2001

1 reference

15 February 2018

published in

Molecular Psychiatry

1 reference

15 February 2018

volume

6

1 reference

15 February 2018

issue

6

1 reference

15 February 2018

page(s)

712-717

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.mp.4000902

exact match

0 references

cites work

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Schizophrenia: developmental neuroscience and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Gender differences in age at onset of schizophrenia. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Long-term Course of Hospitalization for Schizophrenia: Part I. Risk for Rehospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Analytic Considerations about Observed Distribution of Age of Onset in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

Phenylacetic acid in CSF and serum in Indian schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

Plasma phenylethylamine in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

Duration of psychosis and outcome in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

Aspects of the course of bipolar manic-depressive, schizo-affective, and paranoid schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

Age at onset in subtypes of schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000902

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000902

1 reference

15 February 2018

PubMed ID

11673800

1 reference

15 February 2018